Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Asset Writedowns and Impairment: 2009-2020

Historic Asset Writedowns and Impairment for Lexicon Pharmaceuticals (LXRX) over the last 7 years, with Dec 2020 value amounting to $1.6 million.

  • Lexicon Pharmaceuticals' Asset Writedowns and Impairment fell 100.21% to -$2,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $704,000, marking a year-over-year decrease of 49.64%. This contributed to the annual value of $1.6 million for FY2020, which is 94.41% down from last year.
  • According to the latest figures from FY2020, Lexicon Pharmaceuticals' Asset Writedowns and Impairment is $1.6 million, which was down 94.41% from $28.6 million recorded in FY2019.
  • Lexicon Pharmaceuticals' 5-year Asset Writedowns and Impairment high stood at $28.6 million for FY2019, and its period low was $1.6 million during FY2020.
  • Its 2-year average for Asset Writedowns and Impairment is $15.1 million, with a median of $15.1 million in 2019.
  • Data for Lexicon Pharmaceuticals' Asset Writedowns and Impairment shows a maximum YoY slumped of 94.41% (in 2020) over the last 5 years.
  • Lexicon Pharmaceuticals' Asset Writedowns and Impairment (Yearly) stood at $28.6 million in 2019, then crashed by 94.41% to $1.6 million in 2020.